W
HRMY icon

WealthCollab’s Harmony Biosciences HRMY Stock Holding History

WealthCollab’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.52K Buy
179
+134
+298% +$4.23K ﹤0.01% 665
2026
Q1 		$1.26K Hold
45
– – ﹤0.01% 891
2025
Q4 		$1.68K Hold
45
– – ﹤0.01% 916
2025
Q3 		$1.24K Hold
45
– – ﹤0.01% 899
2025
Q2 		$1.42K Buy
+45
New +$1.45K ﹤0.01% 855

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WealthCollab's HRMY Position: Q2 2026 in Review

WealthCollab increased its Harmony Biosciences (HRMY) stake by 298% in Q2 2026, buying an estimated $4.23K and bringing the position to 179 shares worth $6.52K. The position accounts for ﹤0.01% of the portfolio, ranked #665.

WealthCollab first reported a position in HRMY in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • WealthCollab held 179 shares of Harmony Biosciences worth $6.52K as of Q2 2026.
  • WealthCollab bought 134 Harmony Biosciences shares in Q2 2026, an estimated $4.23K.
  • Harmony Biosciences made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #665 holding.
  • WealthCollab first reported a position in Harmony Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.